LYTIX BIOPHARMA AS

0484 OSLO

Finances

Share Ownership

Return on Equity

−41,45 %

Current Ratio

8,99

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	17 273 000	25 827 000	6 678 000	6 698 000
Net Income	−56 007 000	−48 048 000	−42 088 000	−32 415 000
Total Assets	152 017 000	202 962 000	32 617 000	17 434 000
Total Equity	135 126 000	189 624 000	19 889 000	14 392 000

Income (NOK)	2022	2021	2020	2019
Revenue	17 273 000	25 827 000	6 678 000	6 698 000
Expenditure	82 969 000	73 843 000	49 050 000	39 659 000
Operating Profit	−65 696 000	−48 016 000	−42 372 000	−32 961 000
Financial Income	20 902 000	392 000	615 000	884 000
Financial Costs	11 213 000	424 000	331 000	338 000
Financial Balance	9 689 000	−32 000	284 000	546 000
Earnings Before Tax	−56 007 000	−48 048 000	−42 088 000	−32 415 000
Tax	0	0	0	0
Net Income	−56 007 000	−48 048 000	−42 088 000	−32 415 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	124 000	0	0	0
Total Current Assets	151 893 000	202 962 000	32 617 000	17 434 000
Total Assets	152 017 000	202 962 000	32 617 000	17 434 000
Total Retained Equity	0	0	0	0
Total Equity	135 126 000	189 624 000	19 889 000	14 392 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	16 891 000	13 338 000	12 728 000	3 042 000
Total Equity and Debt	152 017 000	202 962 000	32 617 000	17 434 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 409 000	17 000	3 000	310 000
Other Income	15 864 000	25 810 000	6 675 000	6 388 000
Revenue	17 273 000	25 827 000	6 678 000	6 698 000
Cost of Goods Sold	0	0	0	0
Salary Costs	21 133 000	31 605 000	23 416 000	20 103 000
Depreciation	30 000	0	0	0
Impairment	0	0	0	0
Expenditure	82 969 000	73 843 000	49 050 000	39 659 000
Operating Profit	−65 696 000	−48 016 000	−42 372 000	−32 961 000
Financial Income	20 902 000	392 000	615 000	884 000
Financial Costs	11 213 000	424 000	331 000	338 000
Financial Balance	9 689 000	−32 000	284 000	546 000
Dividends	0	0	0	0
Net Income	−56 007 000	−48 048 000	−42 088 000	−32 415 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	124 000	0	0	0
Total Tangible Assets	124 000	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	124 000	0	0	0
Stock	0	0	0	0
Total Investments	50 606 000	0	0	0
Cash, Bank	94 552 000	197 282 000	28 450 000	12 796 000
Total Current Assets	151 893 000	202 962 000	32 617 000	17 434 000
Total Assets	152 017 000	202 962 000	32 617 000	17 434 000
Total Equity	135 126 000	189 624 000	19 889 000	14 392 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	0	0	3 284 000	0
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	16 891 000	13 338 000	9 444 000	3 042 000
Total Current Debt	16 891 000	13 338 000	12 728 000	3 042 000
Total Equity and Debt	152 017 000	202 962 000	32 617 000	17 434 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−41,45 %	−25,34 %	−211,61 %	−225,23 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−380,34 %	−185,91 %	−634,5 %	−492,1 %
Current Ratio	8,99	15,22	2,56	5,73
Quick Ratio	8,99	15,22	2,56	5,73
Equity Ratio	0,89	0,93	0,61	0,83
Gross Profit Margin	100 %	100 %	100 %	100 %